1. Yu, Gyeong Im, Song, Dae Kyu, Shin, Dong Hoon. 2020. Associations of IL1RAP and IL1RL1 gene polymorphisms with obesity and inflammation mediators. In Inflammation research : official journal of the European Histamine Research Society ... [et al.], 69, 191-202. doi:10.1007/s00011-019-01307-y. https://pubmed.ncbi.nlm.nih.gov/31897507/
2. Badi, Yusef Eamon, Salcman, Barbora, Taylor, Adam, Bates, Stewart, Adcock, Ian M. 2022. IL1RAP expression and the enrichment of IL-33 activation signatures in severe neutrophilic asthma. In Allergy, 78, 156-167. doi:10.1111/all.15487. https://pubmed.ncbi.nlm.nih.gov/35986608/
3. Grönberg, Caitríona, Rattik, Sara, Tran-Manh, Cuong, Distler, Jörg Hw, Trinh-Minh, Thuong. 2024. Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis. In Annals of the rheumatic diseases, 83, 1156-1168. doi:10.1136/ard-2023-225158. https://pubmed.ncbi.nlm.nih.gov/38594058/
4. Mulholland, Megan, Depuydt, Marie A C, Jakobsson, Gabriel, Slütter, Bram, Engelbertsen, Daniel. . Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation. In Cardiovascular research, 120, 581-595. doi:10.1093/cvr/cvae046. https://pubmed.ncbi.nlm.nih.gov/38563353/
5. Yu, Zhi, Fidler, Trevor P, Ruan, Yunfeng, Tall, Alan R, Natarajan, Pradeep. 2023. Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk. In The Journal of clinical investigation, 133, . doi:10.1172/JCI168597. https://pubmed.ncbi.nlm.nih.gov/37498674/
智鼠故事 
